What's happened
The Vaccine Damage Payment Scheme has seen rising administration and medical assessor costs, while payouts remain modest. Data show 24,260 claims since November 2021 with 264 successful payments; the total damages paid rose to 31.6 million pounds as of June 2026. The NHSBSA notes costs track the volume of claims, while critics say the scheme is not fit for purpose.
What's behind the headline?
Context and questions for readers
- The scheme exists to provide relief for severe vaccine-related injuries, but rising costs are concentrating scrutiny on its efficiency.
- Critics argue that administrative expenditures dwarf the payouts, while supporters note the program’s purpose and the scale of claims has grown with vaccination campaigns.
- The key tension is whether the benefit to claimants justifies the administrative burden and whether reforms will improve access and speed.
What likely happens next
- Policy review could consider streamlining assessments or recalibrating eligibility thresholds.
- Financial pressures may push the government to adjust funding or restructure how claims are processed.
- Public sentiment may shift toward demands for faster compensation for those injured by vaccines.
How we got here
The Vaccine Damage Payment Scheme was established in 1979 to compensate individuals harmed by vaccines. Since the Covid-19 pandemic, claims have surged, predominantly linked to AstraZeneca and other Covid vaccines. Administrative and medical-review costs have climbed sharply, feeding debate about the scheme’s efficiency and fairness.
Our analysis
BBC News reports that VDPS costs have risen; NHSBSA attributes this to higher claim volumes. The Telegraph and comprehensive parliamentary responses provide figures on staffing, administration, and payouts, with campaign groups arguing the scheme is not fit for purpose.
Go deeper
- Will the government implement a fast-track route for clearly eligible cases?
- How will reforms affect claimants currently in the pipeline?
- What reforms could balance taxpayer costs with patient support?
More on these topics
-
United States - Country in North America
The United States of America, commonly known as the United States or America, is a country mostly located in central North America, between Canada and Mexico.
-
Measles - Viral disease affecting humans
Measles (probably from Middle Dutch or Middle High German masel(e), meaning "blemish, blood blister") is a highly contagious, vaccine-preventable infectious disease caused by measles virus. Other names include morbilli, rubeola, 9-day measles, red measles